413 results on '"Suzuki, Eiichiro"'
Search Results
2. Rational design of a disulfide bridge increases the thermostability of microbial transglutaminase
3. The efficacy of contrast-enhanced computed tomography on the management of gastroesophageal varices in patients with hepatocellular carcinoma
4. Effect of introducing a disulfide bridge on the thermostability of microbial transglutaminase from Streptomyces mobaraensis
5. Liquid Biopsy in Hepatocellular Carcinoma
6. A Prospective Study Exploring the Safety and Efficacy of Lenvatinib for Patients with Advanced Hepatocellular Carcinoma and High Tumor Burden: The LAUNCH Study
7. EZH1/2 inhibition augments the anti-tumor effects of sorafenib in hepatocellular carcinoma
8. The impact of FGF19/FGFR4 signaling inhibition in antitumor activity of multi-kinase inhibitors in hepatocellular carcinoma
9. Sequential therapy with sorafenib and regorafenib for advanced hepatocellular carcinoma: a multicenter retrospective study in Japan
10. Multicenter Retrospective Analysis of Chemotherapy for Advanced Pancreatic Acinar Cell Carcinoma: Potential Efficacy of Platinum- and Irinotecan-Containing Regimens
11. Serum fibroblast growth factor 19 serves as a potential novel biomarker for hepatocellular carcinoma
12. Application of transcutaneous ultrasonography for the diagnosis of muscle mass loss in patients with liver cirrhosis
13. Characteristics of patients with sorafenib-treated advanced hepatocellular carcinoma eligible for second-line treatment
14. Intensity-Based Assessment of Microbubble-Enhanced Ultrasonography: Phase-Related Diagnostic Ability for Cellular Differentiation of Hepatocellular Carcinoma
15. Efficacy of chemotherapy for patients with metastatic or recurrent pancreatic adenosquamous carcinoma: A multicenter retrospective analysis
16. Five Cases of Interstitial Pneumonitis Due to Gemcitabine and Nab-Paclitaxel Combination Treatment in Pancreatic Cancer Patients
17. Left gastric vein-based noninvasive test for esophageal varices: a same-day comparison of portal hemodynamic assessment with endoscopic appearance
18. A randomized placebo‐controlled trial of prophylactic dexamethasone for transcatheter arterial chemoembolization
19. Post-progression survival in patients with advanced hepatocellular carcinoma resistant to sorafenib
20. Liver function assessment according to the Albumin–Bilirubin (ALBI) grade in sorafenib-treated patients with advanced hepatocellular carcinoma
21. A case of hepatocellular carcinoma followed by asynchronous metastasis to the lung and thoracic spine following radical ablation treatment
22. Multicenter Retrospective Analysis of Chemotherapy for Advanced Pancreatic Acinar Cell Carcinoma
23. Sorafenib treatment in Child–Pugh A and B patients with advanced hepatocellular carcinoma: safety, efficacy and prognostic factors
24. Natural history of large regenerative nodules and dysplastic nodules in liver cirrhosis: 28-year follow-up study
25. Incidental tumor necrosis caused by the interventional alteration of hepatic arterial flow in patients with advanced hepatocellular carcinoma
26. Effect of Atezolizumab plus Bevacizumab in Patients with Hepatocellular Carcinoma Harboring CTNNB1 Mutation in Early Clinical Experience
27. Is intra-patient sorafenib dose re-escalation safe and tolerable in patients with advanced hepatocellular carcinoma?
28. Evolution of Survival Impact of Molecular Target Agents in Patients with Advanced Hepatocellular Carcinoma
29. Laparoscopic bypass surgery as palliative treatment for duodenal obstruction due to lymph node metastasis invasion of hepatocellular carcinoma
30. Exploring microsatellite instability in patients with advanced hepatocellular carcinoma and its tumor microenvironment
31. A phase I/II trial of capecitabine combined with peginterferon α-2a in Patients with sorafenib-refractory advanced hepatocellular carcinoma
32. A phase I/II study of S-1 with sorafenib in patients with advanced hepatocellular carcinoma
33. Coronal reformatted CT images contribute to the precise evaluation of the radiofrequency ablative margin for hepatocellular carcinoma
34. Clinical features and natural history of portal vein thrombosis after radiofrequency ablation for hepatocellular carcinoma in Japan
35. Tolvaptan treatment for patients with decompensated cirrhosis and advanced hepatocellular carcinoma
36. Structure and Function of a Pepstatin-Insensitive Acid Proteinase from Aspergillus Niger var. Macrosporus
37. A case of Takotsubo cardiomyopathy after microwave ablation therapy for hepatocellular carcinoma
38. Controlling Major Portal Vein Invasion Progression during Lenvatinib Treatment by Carbon-Ion Radiotherapy in Patients with Advanced Hepatocellular Carcinoma
39. MO38-1 The latest procedure of liver biopsy in the era of cancer genomic therapies; the single center retrospective analysis
40. Sustained virologic response achieved after curative treatment of hepatitis C virus-related hepatocellular carcinoma as an independent prognostic factor
41. Histone lysine methyltransferase SUV39H1 is a potent target for epigenetic therapy of hepatocellular carcinoma
42. Initial response to sorafenib by using enhancement criteria in patients with hepatocellular carcinoma
43. A multicenter phase II study of S-1 for gemcitabine-refractory biliary tract cancer
44. Acquisition of mesenchymal-like phenotypes and overproduction of angiogenic factors in lenvatinib-resistant hepatocellular carcinoma cells
45. Phase I/II study of gemcitabine as a fixed dose rate infusion and S-1 combination therapy (FGS) in gemcitabine-refractory pancreatic cancer patients
46. Screening for improved activity of a transglutaminase from Streptomyces mobaraensis created by a novel rational mutagenesis and random mutagenesis
47. Phase I study of combination chemotherapy using sorafenib and transcatheter arterial infusion with cisplatin for advanced hepatocellular carcinoma
48. A phase II study of S-1 in gemcitabine-refractory metastatic pancreatic cancer
49. Approaching the tumor microenvironment in patients with advanced hepatocellular carcinoma using needle biopsy samples.
50. Transition of molecular target agent therapy in advanced hepatocellular carcinoma: A multicenter, retrospective study.
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.